FY2023 NIH awards · Principal investigators
Pathology at UT MD Anderson Cancer Center
Houston, TX
Funding
$8.9M
$8,912,702
Awards
13
FY2023 NIH awards in Pathology
Principal investigators
10
10 lead a grant here, 0 co-investigators
- NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
- These are the awards in the Pathology row of the UT MD Anderson Cancer Center page.
Leads a grant in this department
10 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.
Maitra, Anirban
Leads 2 awards · $2,596,864
- 5U54CA274371-02Department: NIH department codeTumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer$1,600,526award amount
- 5U01CA200468-07Department: NIH department codeClinical Validation Center for Early Detection of Pancreatic Cancer$996,338award amount
Al-Atrash, Gheath
Leads 1 award · $1,924,560
- 2U24CA224285-02Department: NIH department codeMD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC$1,924,560award amount
Kwong, Lawrence
Leads 2 awards · $1,169,750
- 5R01HG011356-04Department: NIH department codeOptimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations$664,591award amount
- 5R01CA251608-04Department: NIH department codeA Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously$505,159award amount
Lee, J. Jack
Leads 1 award · $972,000
- 5U24CA274274-02Department: NIH department codePASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)$972,000award amount
Kadara, Humam
Leads 2 awards · $949,248
- 5R01CA248731-03Department: NIH department codeInterplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer$520,592award amount
- 5U01CA264583-02Department: NIH department codeSpatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development$428,656award amount
Symmans, William F
Leads 1 award · $369,718
- 1UH3CA276603-01A1Department: NIH department codeEvaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial$369,718award amount
Lin, Sue-Hwa
Leads 1 award · $312,130
- 5R01CA174798-10Department: NIH department codeEndothelial-to-osteoblast transition in prostate cancer bone metastasis$312,130award amount
Ballester, Leomar Y
Leads 1 award · $260,634
- 5K08CA241651-05Department: NIH department codeDevelopment and Validation of a CSF Liquid Biopsy for Molecular Characterization and Monitoring of Patients with Central Nervous System Tumors$260,634award amount
Schenkel, Jason M.
Leads 1 award · $208,026
- 7K08CA256044-03Department: NIH department codeThe ontogeny and function of CD8 T cells in lung cancer$208,026award amount
Kopetz, Scott
Leads 1 award · $149,772
- 5UH3CA207101-05Department: NIH department codeColorectal Cancer Molecular Subtype Assay Development and Validation$149,772award amount